TY  - GEN
AU  - Moiseyev,V S
AU  - Põder,P
AU  - Andrejevs,N
AU  - Ruda,M Y
AU  - Golikov,A P
AU  - Lazebnik,L B
AU  - Kobalava,Z D
AU  - Lehtonen,L A
AU  - Laine,T
AU  - Nieminen,M S
AU  - Lie,K I
TI  - Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN)
SN  - 0195-668X
PY  - 2002///1122
KW  - Acute Disease
KW  - Aged
KW  - Analysis of Variance
KW  - Cardiotonic Agents
KW  - adverse effects
KW  - Double-Blind Method
KW  - Drug Evaluation
KW  - Endpoint Determination
KW  - Female
KW  - Heart Failure
KW  - drug therapy
KW  - Humans
KW  - Hydrazones
KW  - Hypotension
KW  - etiology
KW  - Male
KW  - Myocardial Infarction
KW  - complications
KW  - Prospective Studies
KW  - Pyridazines
KW  - Risk Factors
KW  - Safety
KW  - Simendan
KW  - Survival Analysis
KW  - Treatment Outcome
KW  - Ventricular Dysfunction, Left
N1  - Publication Type: Clinical Trial; Comparative Study; Evaluation Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1053/euhj.2001.3158
ER  -